LARP1 作为预防血管新生素II诱导的心脏功能障碍和纤维化的一个关键调解者
1Department of Cardiology, China-Japan Union Hospital of Jilin University, No. 126, Xiantan Street, Nanguan District, Changchun, 130033, Jilin, China.
Cell & bioscience
|October 23, 2025
概括
与LA相关的蛋白1 (LARP1) 通过稳定ATP2A2 mRNA来保护心脏重塑. 过度表达LARP1可以改善心脏功能,减少病理变化,为心血管疾病提供潜在的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 在RNA生物学,RNA生物学.
背景情况:
- 心脏重塑,包括心肌细胞缩和纤维化,驱动心血管疾病的进展.
- ангиотензин II (Ang II) 加剧心脏重塑,而与La相关的蛋白1 (LARP1) 在这个过程中的作用是未知的.
- 一种RNA结合蛋白LARP1在Ang II诱导的心脏重塑中的功能及其与ATP2A2.2的相互作用方面得到了探索.
研究的目的:
- 调查LARP1在 ангиотензинII诱导的心脏重塑中的作用.
- 阐明LARP1在心脏中的功能背后的分子机制.
- 确定心血管疾病的潜在治疗点.
主要方法:
- 对人类心脏组织中的LARP1表达的分析和Ang II诱导的缩的小鼠模型.
- 在实验室研究中,使用初级心肌细胞和用Ang II治疗的心脏纤维细胞.
- 通过AAV9载体和基因缺陷小鼠调节LARP1表达.
- 使用RNA免疫沉和拉下测试对LARP1-ATP2A2相互作用的研究.
主要成果:
- 在心脏缩和Ang II治疗后,LARP1的表达下调.
- 过度表达LARP1可以改善Ang II诱导的心脏重塑,改善心脏功能和减少纤维化.
- LARP1稳定了ATP2A2mRNA,而ATP2A2过度表达逆转了LARP1缺乏引起的心脏变化.
结论:
- 通过稳定ATP2A2 mRNA,LARP1对Ang II诱导的心脏重塑产生保护作用.
- LARP1代表了预防心脏重塑的潜在治疗标.
- ATP2A2是LARP1在心血管系统中的保护作用的关键媒介.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
01:29Heart Failure II: Pathophysiology
707
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
707
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K